NASDAQ: MGXMetagenomi Inc Stock Ownership - Who owns Metagenomi?
Insider buying vs selling
Have Metagenomi Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Pamela Wapnick | Chief Financial Officer | 2024-12-05 | 1,559 | $1.86 | $2.90kSell |
| Pamela Wapnick | Chief Financial Officer | 2024-09-05 | 6,265 | $2.88 | $18.04kSell |
| Holdings A. Novo | 10% Owner | 2024-02-13 | 800,000 | $15.00 | $12.00MBuy |
| Holdings A. Novo | 10% Owner | 2024-02-09 | 100,000 | $10.25 | $1.03MBuy |
MGX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MGX insiders and whales buy or sell their stock.
MGX Shareholders
What type of owners hold Metagenomi Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Bayer Healthcare LLC | 10.82% | 4,050,997 | $11.18M | Insider |
| Sebastian Bernales | 8.20% | 3,068,786 | $8.47M | Insider |
| Brian C. Thomas | 6.67% | 2,496,276 | $6.89M | Insider |
| Novo Holdings A | 4.81% | 1,800,000 | $4.97M | Institution |
| Holdings A. Novo | 4.65% | 1,739,175 | $4.80M | Insider |
| Ra Capital Management LP | 3.49% | 1,305,239 | $3.60M | Institution |
| Farallon Capital Management LLC | 2.82% | 1,057,201 | $2.92M | Institution |
| Pfm Health Sciences LP | 2.76% | 1,034,002 | $2.85M | Institution |
| Citadel Advisors LLC | 2.15% | 804,462 | $2.22M | Institution |
| Hhlr Advisors Ltd | 2.08% | 777,768 | $2.15M | Institution |
MGX vs Biotech Stocks
Metagenomi Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.